TrialSignal
Clinical trial intelligence report
Impact of Time-Restricted Eating on Metabolic and Neuroendocrine Homeostasis, Inflammation and Oxidative Stress in Patients With Metabolic Syndrome: the TREMNIOS Pilot Clinical Trial
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jul 28, 2026
Report code
NCT04328233-Jul 28, 2026
NCT ID
NCT04328233
Status
UNKNOWN
Phase
NA
Sponsor
Nicolaus Copernicus University
Executive brief
Investment-Ready Snapshot
Impact of Time-Restricted Eating on Metabolic and Neuroendocrine Homeostasis, Inflammation and Oxidative Stress in Patients With Metabolic Syndrome: the TREMNIOS Pilot Clinical Trial is a NA clinical asset sponsored by Nicolaus Copernicus University in Metabolic Syndrome, Overweight or Obesity, PreDiabetes, Weight Loss, Quality of Life. SEO and diligence focus: Time-Restricted Eating, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT04328233
Indication
Metabolic Syndrome
Modality
behavioral intervention
Target
Time-Restricted Eating
Intervention
Time-Restricted Eating
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.